Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 40 min 29 sec ago

Monteris Medical Announces $30 Million Equity Financing

Thu, 11/13/2014 - 13:16
PLYMOUTH, Minn., Nov. 13, 2014 -- (Healthcare Sales & Marketing Network) -- Monteris Medical Corporation (Monteris), a pioneer developer of minimally invasive laser systems for the ablation of pathologic brain lesions such as primary and metastatic tumors...
Devices, Neurosurgery, Venture Capital
Monteris Medical, NeuroBlate

Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel

Thu, 11/13/2014 - 13:11
MISSISSAUGA, ON, Nov. 13, 2014 -- (Healthcare Sales & Marketing Network) - Nuvo Research Inc. (NRI.TO), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has reacquired Pennsaid 2% mark...
Biopharmaceuticals, Distribution
Nuvo Research, Pennsaid 2%, diclofenac

Blueprint Medicines Secures $50 Million in Series C Financing

Wed, 11/12/2014 - 13:45
Proceeds to support continued advancement of highly selective kinase inhibitors to genomically defined cancers, including first-in-class FGFR4 and KIT Exon 17 inhibitors Investor syndicate includes leading public healthcare funds CAMBRIDGE, Mass., No...
Biopharmaceuticals, Oncology, Venture Capital
Blueprint Medicines

Par Pharmaceutical Announces First FDA Approval of Vasostrict(TM) (vasopressin injection, USP)

Wed, 11/12/2014 - 13:40
CHESTNUT RIDGE, N.Y., Nov. 12, 2014 -- (Healthcare Sales & Marketing Network) -- Par Pharmaceutical Companies, Inc. today announced that it has received approval for its New Drug Application (NDA) for Vasostrict™ (vasopressin injection, USP) 20 units/mL f...
Biopharmaceuticals, FDA
Par Pharmaceutical, Vasostrict, vasopressin

Beverly Huss Joins Surefire Medical Board of Directors

Wed, 11/12/2014 - 13:34
WESTMINSTER, Colo., Nov. 12, 2014 -- (Healthcare Sales & Marketing Network) -- The Board of Directors of Surefire Medical, Inc. today announced the appointment of Beverly Huss as a director of the company. Surefire Medical's novel infusion systems are de...
Devices, Interventional, Oncology, Drug Delivery, Personnel
Surefire Medical, embolization

Globus Medical Announces ALTERA(TM) Minimally Invasive Articulating Expandable Spacer

Wed, 11/12/2014 - 13:29
Featured at NASS Booth #1119 AUDUBON, Pa.--(Healthcare Sales & Marketing Network)--Globus Medical, Inc. (GMED), a leading musculoskeletal implant manufacturer, and the worldwide leader in expandable interbody technology, today announced the launch of AL...
Devices, Orthopaedic, Neurosurgery, Product Launch
Globus Medical, ALTERA , interbody fusion, spine surgery

BioCardia(R), Inc. Announces FDA Acceptance of Phase III Clinical Trial Protocol Studying Bone Marrow-Derived Cell Therapy for Heart Failure Patients

Tue, 11/11/2014 - 14:25
Company’s CardiAMP™ Therapy is First Cell Therapy for Heart Failure to be regulated by FDA PMA Pathway and First Cell Therapy/Companion Diagnostic to be Studied Together in a Phase III U.S. Trial SAN CARLOS, Calif.--(Healthcare Sales & Marketing Network...
Regenerative Medicine, Cardiology, FDA
BioCardia, CardiAMP

Titan Pharmaceuticals Appoints Two New Board Members

Tue, 11/11/2014 - 14:16
SOUTH SAN FRANCISCO, CA--(Healthcare Sales & Marketing Network) - Titan Pharmaceuticals, Inc. (OTCBB: TTNP) announced today that it has appointed life sciences industry veterans Joseph A. Akers and James McNab Jr. to its board of directors. Mr. Akers, a fo...
Biopharmaceuticals, Personnel
Titan Pharmaceuticals

St. Mary’s Health Care System Expands Cardiac Imaging with Toshiba MR

Tue, 11/11/2014 - 14:04
Vantage Titan 1.5T MR Delivers More Efficient Cardiac Exams TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--To build leadership in the region for cardiac care, St. Mary’s Health Care System installed two Vantage Titan™ 1.5T MR systems from Toshi...
Devices, Radiology
Toshiba America Medical Systems, Vantage Titan, MR, imaging

Zimmer Announces FDA Clearance of the Stand-alone Optio-C(R) Anterior Cervical System for use with Structural Allograft/Autograft

Mon, 11/10/2014 - 15:38
The Optio-C System is a next-generation, modular stand-alone cervical device that offers allograft/autograft and PEEK options and delivers the strength, stability and fusion potential of a traditional ACDF MINNEAPOLIS, Nov. 10, 2014 -- (Healthcare Sales...
Devices, Orthopaedic, Neurosurgery, FDA
Zimmer Spine, Optio-C, Anterior Cervical Plate, spine surgery

ImThera Medical, Inc. Receives FDA Approval for Pivotal Study for Obstructive Sleep Apnea Device

Mon, 11/10/2014 - 15:31
THN3 Study Will Expand the Clinical Evidence for this Novel Neurostimulation Therapy for Moderate to Severe Obstructive Sleep Apnea SAN DIEGO, Nov. 10, 2014 -- (Healthcare Sales & Marketing Network) -- ImThera Medical, Inc., a privately held global med...
Devices, FDA
ImThera Medical, THN3 Study, aura6000, obstructive sleep apnea

BSD Medical Names Medical Device Veteran Clint Carnell President and Chief Executive Officer

Mon, 11/10/2014 - 15:14
Brings Track Record of Proven Leadership and Commercial Success SALT LAKE CITY--(Healthcare Sales & Marketing Network)--BSD Medical Corporation (BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, tod...
Devices, Oncology, Personnel
BSD Medical, MicroThermX, hyperthermia

Southern Spine adds new Dual Lamina configuration to its StabiLink(R) “Ultimate MIS” Spinal Fixation System

Mon, 11/10/2014 - 15:08
MACON, Ga.--(Healthcare Sales & Marketing Network)--Southern Spine, LLC, an ISO 13485:2003 certified manufacturer of implants and instruments for spinal surgery, announced today that they have added the Dual Lamina configuration with Laminar-LockTM technol...
Devices, Orthopaedic, Neurosurgery, Product Launch
Southern Spine, Dual Lamina, StabiLink, Spinal Fixation

NeoTract, Inc. Announces CMS Reimbursement for Innovative Minimally Invasive Procedure for Enlarged Prostate

Mon, 11/10/2014 - 15:05
Category I CPT Codes Will Expand Patient Access to Novel Treatment for Common Condition that Significantly Impacts Quality of Life PLEASANTON, Calif.--(Healthcare Sales & Marketing Network)--NeoTract, Inc., a medical device company focused on addressing...
Devices, Urology, Reimbursement
NeoTract, UroLift, benign prostatic hyperplasia, BPH

Finding Medical Independent Sales Reps and Saving Money: RepFinder USA Updated for iOS 8

Fri, 11/07/2014 - 22:38
HSMN's Disruptive Alternative to Recruiting Medical Sales Reps Now Optimized for iPhone 6 and iPhone 6 Plus Available Now on the Apple App Store PHILADELPHIA - November 7, 2014 -- The Healthcare Sales & Marketing Network (HSMN) announced today that R...
Devices, Distribution
Independent Sales Rep

MiMedx(R) Adds New Executive

Fri, 11/07/2014 - 14:31
CHRISTOPHER CASHMAN JOINS MIMEDX AS ITS EXECUTIVE VICE PRESIDENT & CHIEF COMMERCIALIZATION OFFICER MARIETTA, Ga., Nov. 7, 2014 -- (Healthcare Sales & Marketing Network) -- MiMedx Group, Inc. (MDXG), the leading regenerative medicine company utilizing h...
Regenerative Medicine, Personnel
MiMedx Group

Study Using MarginProbe(R) Presented at American Society of Clinical Oncology (ASCO) 2014 Breast Cancer Symposium

Fri, 11/07/2014 - 14:23
PAOLI, Pa., Nov. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Results of the study Combined experience at three breast centers with routine use of an intraoperative margin assessment device including comparison to historical re-excision rates were...
Dune Medical Devices, MarginProbe, breast cancer

Myriad myPath(TM) Melanoma Improves Diagnosis and Treatment Plans

Fri, 11/07/2014 - 14:17
New Prospective Clinical Utility Data Presented at the ASDP Annual Meeting SALT LAKE CITY, Nov. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Myriad Genetics, Inc. (MYGN) today presented results from a prospective clinical utility study of its My...
Diagnostics, Dermatology, Oncology
Myriad Genetics, myPath Melanoma, malignant melanoma

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong